Eric Langer

BioPlan Associates

Eric Langer has over 25 years experience in biotechnology and life sciences strategic marketing management, market research, and publishing. He has held senior management and marketing positions at biopharmaceutical supply companies. He has published and authored many books and reports on topics in Biotechnology, Large-scale BioManufacturing, and bioscience commercialization and communication. He teaches at Johns Hopkins University marketing management, biotech marketing, services marketing, and marketing in a regulated environment. In 1989 he co-founded BioPlan Associates, Inc. to provide market analysis, and strategy to biotech and healthcare organizations.

Articles

Biomanufacturing: Demand for Continuous Bioprocessing Increasing

But are innovations sufficient to increase adoption? CMOs are demanding better continuous bioprocessing options.

CMOs Leading the Way on Single-Use Systems Adoption

Single-use systems can be a cost savings for CMOs, and these savings can be passed on to clients and, ultimately, to patients.

The Outlook for CMO Outsourcing in 2019

Outsourcing of manufacturing activities is expected to increase in 2019.

Single-Use Bioprocessing Equipment Trends and Adoption by CMOs

The growth in adoption of single-use systems for commercial manufacturing will be dramatic in coming years.

Fifteen Years of Progress: Biopharmaceutical Industry Survey Results

This article highlights 15 years of changes in biopharmaceutical manufacturing.

Update on Continuous Bioprocessing: From the Industry’s Perception to Reality

Although widespread adoption of continuous bioprocessing has been slow, some processes have been an exception.

Fill/Finish Outsourcing

This key bioprocessing segment is expecting continued growth.

Downstream Processing Continues to Worry CMOs

CMOs are working hard to improve performance by investigating new technologies for filtration and purification.

Biomanufacturers Demand Higher Quality Standards in 2016

Biopharmaceutical manufacturers continue to put quality at the forefront of their relationships.

Outsourcing of Biomanufacturing in 2016

Growth may be slowing, but outsourcing activity remains healthy.